These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 1664073)
1. Characterisation of [3H]ceranapril recognition sites in rat and human brain tissue. Barnes NM; Costall B; Egli P; Horovitz ZP; Ironside JW; Naylor RJ; Williams TJ Neuropharmacology; 1991 Aug; 30(8):907-14. PubMed ID: 1664073 [TBL] [Abstract][Full Text] [Related]
2. The ACE inhibitor [3H]SQ29,852 identifies a high affinity recognition site located in the human temporal cortex. Barnes NM; Costall B; Egli P; Horovitz ZP; Ironside JW; Naylor RJ; Williams TJ Brain Res Bull; 1990 Jul; 25(1):183-5. PubMed ID: 2207707 [TBL] [Abstract][Full Text] [Related]
3. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE). Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's disease. Barnes NM; Cheng CH; Costall B; Naylor RJ; Williams TJ; Wischik CM Eur J Pharmacol; 1991 Aug; 200(2-3):289-92. PubMed ID: 1664329 [TBL] [Abstract][Full Text] [Related]
5. Ceranapril (SQ 29,852), an orally active inhibitor of angiotensin converting enzyme (ACE). DeForrest JM; Waldron TL; Harvey C; Scalese R; Hammerstone S; Powell JR; Karanewsky D J Cardiovasc Pharmacol; 1990 Jul; 16(1):121-7. PubMed ID: 1696654 [TBL] [Abstract][Full Text] [Related]
6. Characterization of angiotensin converting enzyme by [3H]captopril binding. Strittmatter SM; Snyder SH Mol Pharmacol; 1986 Feb; 29(2):142-8. PubMed ID: 3005826 [TBL] [Abstract][Full Text] [Related]
7. The reduction in alcohol intake produced by enalapril is not attenuated by centrally administered angiotensin inhibitors. Robertson JM; Harding S; Grupp LA Alcohol; 1994; 11(4):295-9. PubMed ID: 7945983 [TBL] [Abstract][Full Text] [Related]
8. [3H]Captopril binding to membrane associated angiotensin converting enzyme. Strittmatter SM; Kapiloff MS; Snyder SH Biochem Biophys Res Commun; 1983 May; 112(3):1027-33. PubMed ID: 6303332 [TBL] [Abstract][Full Text] [Related]
9. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding. Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of endothelial-bound angiotensin converting enzyme, in vivo. Catravas JD; Ryan JW; Chung AY; Quinn NE; Anthony BL Br J Pharmacol; 1990 Sep; 101(1):121-7. PubMed ID: 2282454 [TBL] [Abstract][Full Text] [Related]
11. Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: in vitro and preclinical in vivo pharmacology. DeForrest JM; Waldron TL; Harvey C; Scalese B; Rubin B; Powell JR; Petrillo EW; Cushman DW J Cardiovasc Pharmacol; 1989 Nov; 14(5):730-6. PubMed ID: 2481187 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the steady-state pharmacokinetics of fosinopril, lisinopril and enalapril in patients with chronic renal insufficiency. Sica DA; Cutler RE; Parmer RJ; Ford NF Clin Pharmacokinet; 1991 May; 20(5):420-7. PubMed ID: 1652404 [TBL] [Abstract][Full Text] [Related]
13. Autoradiographic visualization of angiotensin-converting enzyme in rat brain with [3H]captopril: localization to a striatonigral pathway. Strittmatter SM; Lo MM; Javitch JA; Snyder SH Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1599-603. PubMed ID: 6324207 [TBL] [Abstract][Full Text] [Related]